Drug Profile
Milacemide
Alternative Names: CP 1552SLatest Information Update: 05 Oct 2001
Price :
$50
*
At a glance
- Originator Continental Pharma
- Class Antidepressants; Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Glycine agonists; Glycine gated NMDA receptor agonists; Monoamine oxidase B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease; Psychotic disorders
- Discontinued Epilepsy
Most Recent Events
- 05 Oct 2001 Discontinued-III for Epilepsy in United Kingdom (Unknown route)
- 05 Oct 2001 Discontinued-III for Epilepsy in USA (Unknown route)
- 04 Oct 2001 No-Development-Reported for Alzheimer's disease in United Kingdom (Unknown route)